Miao Liu

14PUBLICATIONS
17CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Wastewater treatment processesCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 10, 2026
Targeting PCSK9 in Vascular Smooth Muscle Cells: An Effective Strategy to Suppress Ferroptosis and Attenuate Abdominal Aortic Aneurysm Progression.

|Feb 12, 2026
AlphaGenome-enabled analysis of non-coding regulatory variants underlying RHD expression with wet-lab validation.

Miao Liu, Ziyang Shen, You Kyeong Jeong

|Nov 25, 2025
Computer-aided design enables repurposing of proprotein convertase subtilisin/kexin type 9 degrader from cholesterol-lowering to colon cancer therapy.

Gang Fan, Jinhui Zha, Shilin Chen

|May 14, 2025
Targeting transcription factors through an IMiD independent zinc finger domain.

Bee Hui Liu, Miao Liu, Sridhar Radhakrishnan

|Nov 18, 2024
Correction: Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates.

Yu-Ying Shi, Gang Fan, Ruirong Tan

|Sep 30, 2024
Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates.

Yu-Ying Shi, Gang Fan, Ruirong Tan

Pageof 3

Frequent Collaborators

3 joint publications

Rui Li

3 joint publications

Ruirong Tan

2 joint publications

Hua-Bing Sun

2 joint publications

Meng-Yuan Dai